Inspire Medical Systems investigation
Analysis based on 6 articles · First reported Jun 29, 2026 · Last updated Jul 24, 2026
The investigation and ongoing lawsuit may negatively impact investor confidence in Inspire Medical Systems, potentially affecting its stock price. The company's reduced earnings guidance and launch delays already indicate operational challenges.
Kahn Swick & Foti, LLC (KSF) continues its investigation into Inspire Medical Systems, Inc. (NYSE: INSP) regarding potential breaches of fiduciary duties by officers and directors. In August 2025, Inspire disclosed delays in the launch of its Inspire V device due to undisclosed issues, including incomplete training and software updates, and slashed its 2025 earnings guidance by over 80%. Subsequently, a securities class action lawsuit was filed against the company and certain executives, which was transferred from the Southern District of New York to the District of Minnesota. KSF's investigation focuses on whether Inspire's officers and directors violated state or federal laws.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard